Glenmark Pharma gets US FDA approval for skin cream

New Delhi, Sept 25 (UNI) Glenmark Pharmaceuticals Ltd today said its generics unit has received approval from the US Food and Drug Administration(USFDA) for sale of betamethasone dipropionate skin cream in the United States.

The drug, a generic form of Schering-Plough's Diprolene AF cream, is a corticosteroid used to treat swelling, itching and allergic reactions.

It is the eighth steroidal skin product in the company's portfolio targeting an overall segment value of 60 million dollars, it said in a statement.

Glenmark has over 35 abbreviated new drug applications (ANDA) pending approval with the US FDA, of which seven are in the dermatology segment.

UNI AK SG AS1544